on January 8, 2004
Published online before print January 8, 2004, doi: 10.1161/01.STR.0000111599.77426.A0
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on October 1, 2003
From the Departments of Neurology (M.L., C.C.E., G.D.) and Pharmacology (T.H., S.B.) Christian-Albrechts University of Kiel, Kiel, Germany, and Department of Neurology, Second Affiliated Hospital, Zhejiang University, Hangzhou, Peoples Republic of China (M.L.). * To whom correspondence should be addressed. E-mail: c.eschenfelder{at}neurologie.uni-kiel.de.
Background and Purpose--Hyperbaric oxygenation (HBO) is an attractive procedure that has been used frequently in cerebral ischemia. However, depending on the model of cerebral ischemia and HBO protocol, different and conflicting results were obtained in the past. This study was undertaken to reevaluate the effects of single administration of HBO in 2 models of acute cerebral ischemia: transient or permanent focal ischemia in rats. A comparison of the 2 ischemia models was undertaken to search for a putative therapeutic window. Methods--The intraluminal middle cerebral artery occlusion model (MCAO) was used. The effect of single HBO therapy (3 atm absolute, 60 minutes) on transient or permanent focal ischemia, when applied at different times (3, 6, or 12 hours) after MCAO, was investigated; infarct volume and neurological deficits were assessed at 24 hours and up to 7 days. Results--HBO had neuroprotective effects on transient MCAO when HBO was initiated within the first 6 hours, while it aggravated the ischemic injury histologically and clinically when initiated 12 hours after MCAO. In permanent MCAO, HBO did not reduce tissue damage regardless of the timing of therapy. Conclusions--HBO is highly efficient in reducing infarct volume and improving neurobehavioral outcome in transient MCAO within the first 6 hours. HBO at later time points (
Accepted on October 20, 2003
Therapeutic Window for Use of Hyperbaric Oxygenation in Focal Transient Ischemia in Rats
Min Lou MD;
12 hours) is harmful by increasing infarct volume. In permanent MCAO, HBO failed to improve infarct volume and clinical outcome.
Key words: animal models • cerebral infarction • hyperbaric oxygenation • ischemia • middle cerebral artery occlusion • outcome • time factors • rats
This article has been cited by other articles:
 |
|
 |
|
  L. Sun, H. H. Marti, and R. Veltkamp Hyperbaric Oxygen Reduces Tissue Hypoxia and Hypoxia-Inducible Factor-1{alpha} Expression in Focal Cerebral Ischemia Stroke, March 1, 2008; 39(3): 1000 - 1006. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Qin, M. Karabiyikoglu, Y. Hua, R. Silbergleit, Y. He, R. F. Keep, and G. Xi Hyperbaric Oxygen-Induced Attenuation of Hemorrhagic Transformation After Experimental Focal Transient Cerebral Ischemia Stroke, April 1, 2007; 38(4): 1362 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Veltkamp, D. A. Siebing, L. Sun, S. Heiland, K. Bieber, H. H. Marti, S. Nagel, S. Schwab, and M. Schwaninger Hyperbaric Oxygen Reduces Blood-Brain Barrier Damage and Edema After Transient Focal Cerebral Ischemia Stroke, August 1, 2005; 36(8): 1679 - 1683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. B. Singhal, T. Benner, L. Roccatagliata, W. J. Koroshetz, P. W. Schaefer, E. H. Lo, F. S. Buonanno, R. G. Gonzalez, and A. G. Sorensen A Pilot Study of Normobaric Oxygen Therapy in Acute Ischemic Stroke Stroke, April 1, 2005; 36(4): 797 - 802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Potrovita, W. Zhang, L. Burkly, K. Hahm, J. Lincecum, M. Z. Wang, M. H. Maurer, M. Rossner, A. Schneider, and M. Schwaninger Tumor Necrosis Factor-Like Weak Inducer of Apoptosis-Induced Neurodegeneration J. Neurosci., September 22, 2004; 24(38): 8237 - 8244. [Abstract] [Full Text] [PDF]
|
|